MeiraGTx Holdings PLC AAV-hAQP1 Clinical Program Update Call Transcript
Good morning. MeiraGTx program update. (Operator Instructions) As a reminder, this call is being recorded, and a replay will be made available on the MeiraGTx website following the conclusion of the event. I'd now like to turn the call over to Zandy Forbes, President and Chief Executive Officer of MeiraGTx. Please go ahead.
Thank you for joining us today as we get update on our AAV-hAQP1 program for the treatment of radiation-induced xerostomia. Before we begin, please note that we will be making forward-looking statements as part of this presentation, which statements are subject to certain risks and uncertainties that may cause actual results, performance or achievements to materially differ from those forecasted. Certain of these risks are described in Slide 2 of today's presentation and in our most recent filings with the SEC.
I'm Zandy Forbes, the President and CEO of MeiraGTx. I'm joined by Dr. Robert Zeldin, our Chief Medical Officer. Today, we will review the data from the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |